Source: Acrofan

Lysogene: Lysogene announces the opening of a safeguard proceeding

Read full article »

Lysogene's Competitors | Lysogene's News | Lysogene's Financials

Followers on Owler

Annual Revenue

$5.0-25M

Employees

1-25

Chairman & CEO

Karen Pignet-Aiach

CEO Approval Rating

90/100

Lysogene is a France-based biopharmaceutical company that researches and develops gene therapies for the treatment of central nervous system diseases.